UBS Group’s Corgi U.S. Biotech 2x Daily ETF XBIX Stock Holding History

UBS Group’s Portfolio XBIX Stock Details XBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$36	Buy	+1	New	+$37	﹤0.01%	10965

UBS Group's XBIX Position: Q3 2026 in Review

UBS Group opened a new position in Corgi U.S. Biotech 2x Daily ETF (XBIX) in Q3 2026: 1 share worth $36. The stake represents ﹤0.01% of the portfolio and ranks #10965 among its holdings.

1 fund tracked by Wall St. Rank holds XBIX as of Q3 2026.

UBS Group held 1 share of Corgi U.S. Biotech 2x Daily ETF worth $36 as of Q3 2026.
Corgi U.S. Biotech 2x Daily ETF was a new UBS Group position in Q3 2026.
Corgi U.S. Biotech 2x Daily ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10965 holding.
1 fund tracked by Wall St. Rank held Corgi U.S. Biotech 2x Daily ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.